Literature DB >> 15626591

Control of cyclooxygenase-2 transcriptional activation by pro-inflammatory mediators.

K K Wu1.   

Abstract

Cyclooxygenase-2 (COX-2) plays a key role in diverse inflammatory conditions. Its cellular levels depend on transcriptional activation by pro-inflammatory mediators. The mechanism by which phorbol esters and cytokines activate COX-2 gene expression has been extensively characterized. Several endogenous molecules and natural products have been reported to inhibit COX-2 expression by targeting at the transcriptional activation induced by pro-inflammatory mediators. This review highlights the importance of C/EBP beta and NF-kappa B in COX-2 transcriptional activation by proinflammatory mediators and as targets of inhibition by endogenous molecules such as melatonin and natural products including salicylate and polyphenols.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15626591     DOI: 10.1016/j.plefa.2004.11.001

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  24 in total

1.  Effects of melatonin and age on gene expression in mouse CNS using microarray analysis.

Authors:  Edward H Sharman; Stephen C Bondy; Kaizhi G Sharman; Debomoy Lahiri; Carl W Cotman; Victoria M Perreau
Journal:  Neurochem Int       Date:  2006-11-21       Impact factor: 3.921

Review 2.  COX-2 inhibitors as adjunctive therapy in schizophrenia: rationale for use and evidence to date.

Authors:  Michael Riedel; Martin Strassnig; Markus J Schwarz; Norbert Müller
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Dioxin-induced increase in leukotriene B4 biosynthesis through the aryl hydrocarbon receptor and its relevance to hepatotoxicity owing to neutrophil infiltration.

Authors:  Tomoki Takeda; Yukiko Komiya; Takayuki Koga; Takumi Ishida; Yuji Ishii; Yasushi Kikuta; Michio Nakaya; Hitoshi Kurose; Takehiko Yokomizo; Takao Shimizu; Hiroshi Uchi; Masutaka Furue; Hideyuki Yamada
Journal:  J Biol Chem       Date:  2017-05-09       Impact factor: 5.157

4.  The effect of melatonin on endotoxemia-induced intestinal apoptosis and oxidative stress in infant rats.

Authors:  Durgul Ozdemir; Nazan Uysal; Kazim Tugyan; Sevil Gonenc; Osman Acikgoz; Ilkay Aksu; Hasan Ozkan
Journal:  Intensive Care Med       Date:  2006-12-22       Impact factor: 17.440

Review 5.  Morphogenesis of pancreatic cancer: role of pancreatic intraepithelial neoplasia (PanINs).

Authors:  Jan-Bart M Koorstra; Georg Feldmann; Nils Habbe; Anirban Maitra
Journal:  Langenbecks Arch Surg       Date:  2008-02-19       Impact factor: 3.445

6.  Antihyperalgesic and anti-inflammatory effects of atorvastatin in chronic constriction injury-induced neuropathic pain in rats.

Authors:  Nitya N Pathak; Venkanna Balaganur; Madhu C Lingaraju; Amar S More; Vinay Kant; Dhirendra Kumar; Dinesh Kumar; Surendra Kumar Tandan
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

7.  Effects of propofol on the leukocyte nitric oxide pathway: in vitro and ex vivo studies in surgical patients.

Authors:  J A González-Correa; E Cruz-Andreotti; M M Arrebola; J A López-Villodres; M Jódar; J P De La Cruz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-12-07       Impact factor: 3.000

Review 8.  Reactive oxygen species and the hypomotility of the gall bladder as targets for the treatment of gallstones with melatonin: a review.

Authors:  Sreedevi Koppisetti; Bharat Jenigiri; M Pilar Terron; Sandra Tengattini; Hiroshi Tamura; Luis J Flores; Dun-Xian Tan; Russel J Reiter
Journal:  Dig Dis Sci       Date:  2008-03-13       Impact factor: 3.199

9.  2-Chlorohexadecanal and 2-chlorohexadecanoic acid induce COX-2 expression in human coronary artery endothelial cells.

Authors:  Maria C Messner; Carolyn J Albert; David A Ford
Journal:  Lipids       Date:  2008-05-21       Impact factor: 1.880

10.  Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells.

Authors:  C Martínez-Campa; A González; M D Mediavilla; C Alonso-González; V Alvarez-García; E J Sánchez-Barceló; S Cos
Journal:  Br J Cancer       Date:  2009-09-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.